Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Seminars in Nephrology|December 24, 2022
Kidney Organ Allocation System: How to Be FairMelissa Y Yeung, P Toby Coates, Philip Kam-Tao Li
Seminars in Nephrology|January 10, 2024
COVID and the Kidney: An UpdateSamira Bell, Griffith B Perkins, Urmila Anandh, et al.
Kidney International|June 29, 2021
The emerging field of non-human leukocyte antigen antibodies in transplant medicine and beyondCarmen Lefaucheur, Kevin Louis, Aurélie Philippe, et al.
International Journal of Nephrology|August 6, 2016
Prevalence of Hypercalcaemia in a Renal Transplant Population: A Single Centre StudyTony Amin, P Toby Coates, Jeffrey Barbara, et al.
Nephrology (Carlton, Vic.)|January 16, 2009
Immunophenotyping of interstitial infiltrate does not distinguish between BK virus nephropathy and acute cellular rejectionNatasha M Rogers, Graeme R Russ, John Cooper, et al.
Kidney International|May 1, 2021
Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapyT Alp Ikizler, P Toby Coates, Brad H Rovin, et al.
Nephrology (Carlton, Vic.)|November 5, 2011
Urinary tubular biomarkers as potential early predictors of renal allograft rejectionYi-Tian Ting, P Toby Coates, Robert J Walker, et al.
Transplantation|November 9, 2007
Parental donors in live-donor kidney transplantation associated with increased rejection rates and reduced glomerular filtration ratesWai H Lim, Sean H Chang, P Toby Coates, et al.
Clinical Transplantation|February 6, 2023
Do patient decision aids help people who are facing decisions about solid organ transplantation? A systematic reviewGeorgina L Irish, Alison Weightman, Jolyn Hersch, et al.
Stem Cell Reviews and Reports|February 11, 2014
Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantationKisha Nandini Sivanathan, Stan Gronthos, Darling Rojas-Canales, et al.
Pageof 7